Search Results - "Parrinello, Nunziatina L"
-
1
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma
Published in Cell death & disease (20-09-2019)“…Inflammation represents a key feature and hallmark of tumor microenvironment playing a major role in the interaction with mesenchymal stromal cells (MSC) in…”
Get full text
Journal Article -
2
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload
Published in International journal of molecular sciences (31-01-2019)“…Iron toxicity is associated with organ injury and has been reported in various clinical conditions, such as hemochromatosis, thalassemia major, and…”
Get full text
Journal Article -
3
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib
Published in Redox biology (01-09-2020)“…Iron plays a major role in multiple processes involved in cell homeostasis such as metabolism, respiration and DNA synthesis. Cancer cells exhibit pronounced…”
Get full text
Journal Article -
4
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM)
Published in Nutrients (01-10-2016)“…Multiple myeloma (MM) is a clonal B-cell malignancy characterized by an accumulation of clonal plasma cells (PC) in the bone marrow (BM) leading to bone…”
Get full text
Journal Article -
5
Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia
Published in Frontiers in pharmacology (26-04-2017)“…Azacytidine (5-AZA) is the standard first-choice treatment for high-risk myelodysplasia (MDS) patients. However, the clinical outcome for those patients who…”
Get full text
Journal Article -
6
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells
Published in Frontiers in pharmacology (14-10-2015)“…Osteolytic bone disease is a common manifestation of multiple myeloma (MM) that leads to progressive skeleton destruction and is the most severe cause of…”
Get full text
Journal Article -
7
Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells
Published in Frontiers in oncology (21-05-2015)“…The better definition of the mutual sustainment between neoplastic cells and immune system has been translated from the bench to the bedside acquiring value as…”
Get full text
Journal Article -
8
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)
Published in Oncotarget (27-12-2016)“…Granulocytic-Myeloid-derived suppressor cells (G-MDSC) are increased in Multiple Myeloma (MM) patients but the mechanisms of G-MDSC generation are still…”
Get full text
Journal Article -
9
Immune off‐target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma
Published in British journal of haematology (01-05-2019)“…Summary Hodgkin Lymphoma (HL) is associated with deep microenvironment re‐shaping and myeloid dysfunction. Given that only limited data are available regarding…”
Get full text
Journal Article -
10
Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib
Published in Journal of cellular and molecular medicine (01-02-2018)“…Myeloid suppressor cells are a heterogeneous group of myeloid cells that are increased in patients with chronic myeloid leukaemia (CML) inducing T cell…”
Get full text
Journal Article -
11
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma
Published in Cell death & disease (28-10-2019)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
12
Plasmocytosis and Immunoparesis but Not Neutrophil to Lymphocyte Ratio Can Predict Time to Treatment in Smoldering Myeloma
Published in Blood (03-12-2015)“…Objectives: We recently identified the ratio between absolute neutrophils count and absolute lymphocyte count, NLR ≥2, as a predictor of progression free…”
Get full text
Journal Article -
13
Contribution of High-Density Neutrophils to Multiple Myeloma Microenvironment Dysregulation
Published in Blood (02-12-2016)“…Background and objective: Multiple Myeloma (MM) is a plasma cell malignancy with a well documented immune dysfunction. Previous reports in murine models and…”
Get full text
Journal Article -
14
Mesenchymal STEM CELLS Favor Tumor Growth By Generating Granulocyte-like Myeloid Derived Suppressor CELLS in CML Patients
Published in Blood (03-12-2015)“…INTRODUCTION. The complex interplay between cancer cells and immune system allows neoplastic cells to evade immune surveillance and expand. Recently, our and…”
Get full text
Journal Article -
15
Monocytic Myeloid Derived Suppressor CELLS (M-MDSC) As Prognostic Factor in Chronic Myeloid Leukemia Patients Treated with Dasatinib
Published in Blood (03-12-2015)“…INTRODUCTION. Myeloid suppressor cells are a heterogeneous group of myeloid cells that are increased in most cancer patients. Recently, we and another group…”
Get full text
Journal Article -
16
Arginase 1 Is a Marker of Myeloid-Mediated Immunosuppression with Prognostic Meaning in Classic Hodgkin Lymphoma
Published in Blood (02-12-2016)“…Purpose: Neutrophilia is hallmark of classic Hodgkin Lymphoma (cHL), but its precise characterization remains elusive. We aimed at investigating the…”
Get full text
Journal Article -
17
Immune Suppression By High-Density Neutrophils Predicts Short Progression-Free Survival in Multiple Myeloma
Published in Blood (02-12-2016)“…Background and Objective: Our previous work showed that neutrophils sedimenting on top of red cells after density gradients, defined as high-density…”
Get full text
Journal Article